9071 Background: Despite its direct correlation with quality of life, sexual dysfunction is under-discussed and underreported in patients with lung cancer (LC). Sexual dysfunction is highly prevalent in patients with LC, with issues persisting over time; however, most data precede the approval of targeted therapies and immune checkpoint inhibitors. We report updated data from the SHAWL study, focusing on women’s sex life satisfaction. Methods: This cross-sectional, international survey study was administered via the GO2 Foundation Lung Cancer Registry. We utilized the Patient-Reported Outcomes Measurement Information System (PROMIS) Sexual Function and Satisfaction Measures for data collection. Participants were recruited from June 2020 to June 2021. Eligibility criteria included age > 18 years, self-identification as a woman, and an LC diagnosis within ten years. Participants were asked about sexual health pertaining to 30 days before survey completion, now referred to as “recent.” Re